Formation des sous-produits de désinfection par différents traitements à base de chlore conçus pour traiter l'eau potable à domicile
|Advisor:||Dorea, Caetano Chang; Bouchard, Christian|
|Abstract:||Point of use treatment is recommended by the World health organisation (WHO) to reduce diarrhoeal diseases, by preventing microbial contamination of drinking water. Coagulant-disinfectant products (CDP) and disinfection combined to safe storage practices are among the point of use treatments recommended by the WHO. Since microbial reduction performances of these products are well documented, little is known about the disinfection by-products (DBP) formed by the reaction of the free chlorine they contain, with the dissolved organic matter present in the water. This project aimed to characterize the formation of DBP by 4 point of use treatments in 3 different water source (swamp, St-Laurent River and laboratory synthetic water). 2 of the 4 tested products were CDP (PUR® and Aquafloq®), and the 2 others didn’t have coagulant (sodium hypochlorite (NaOCl) solution and Aquatabs® tablets). Trihalomethane (THM) en haloacetic acids (HAA) concentrations in treated water were measured at 4 different time steps: 30 min, 1h, 4h, and 24h. On the 15 tests realized, 6 of them had DBP concentrations that exceeded the WHO guidelines. Maximum THM4 (415 ppb) and HAA5 (335 ppb) concentrations were obtained with double dose NaOCl (8,4 mg Cl2/L) in the swamp. Alternative methods allowing estimation of DBP formation concentrations (e.g. differential UV absorbance (DUVA) and chlorine consumption (CLC)) were also investigated. Their performances varied according to the DBP’s nature (from R2 =0.69, for THM4 with CLC, to R2 =0.98, for HAA5 with DUVA).|
|Document Type:||Mémoire de maîtrise|
|Open Access Date:||24 April 2018|
|Collection:||Thèses et mémoires|
All documents in CorpusUL are protected by Copyright Act of Canada.